BR
Bio-Raid specializes in the research, development, and pilot testing of CAR-T cell therapies for cancer treatment. The company focuses on creating targeted immune cell drugs that enhance the body's ability to combat specific malignancies, addressing the need for more effective cancer therapies.
Wuhan, China
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Bio-Raid specializes in the research, development, and pilot testing of CAR-T cell therapies for cancer treatment. The company focuses on creating targeted immune cell drugs that enhance the body's ability to combat specific malignancies, addressing the need for more effective cancer therapies.